Key Highlights

  • Marvell Technology (NASDAQ:MRVL) agreed on November 2, 2026 to acquire Lumentum in an all-stock transaction with an implied Enterprise value of USD 115 billion, at a fixed 4.500 Marvell shares per Lumentum share.
  • The terms equal about USD 1,132 per Lumentum share, a premium near 23.9% to the unaffected October 28 close, and Marvell holders will own roughly 67% of the combined company.
  • Marvell sees more than USD 1 billion of annual run-rate cost synergies and expects non-GAAP EPS accretion in year one after closing, which is targeted for the first half of 2028.
  • BofA cut Marvell to Neutral from Buy and reduced its target to USD 225 from USD 400, citing roughly 50% share-count dilution, a long regulatory review and channel conflict.

What the Deal Looks Like

Marvell Technology (NASDAQ:MRVL) will pay entirely in stock, so no new financing is required. Lumentum (NASDAQ:LITE) holders receive 4.500 Marvell shares for each of theirs, and the companies say the combination spans electrical and optical interconnect, switching, custom silicon, lasers, transceivers and optical circuit switching. Matt Murphy stays as Chairman and CEO, and three Lumentum directors, including CEO Michael Hurlston, will join a seven-member Marvell board. Completion needs both Shareholder votes, regulatory approvals and a Form S-4 filing. Marvell puts the expanded addressable market at USD 550 billion, a company estimate. The goal is co-designed optical solutions that cut customer time to market, and the deal brings Lumentum's indium phosphide and compound semiconductor Manufacturing capacity.

The Market Reaction

The response was sharp. Published market data showed Marvell down about 12.7% and Lumentum down about 18.6% on November 2, even though Lumentum had climbed 243% over the past year before the announcement and had already dropped 21% in the prior week. BofA argued that USD 1 billion of savings would not offset the dilution, that Marvell sells chips to optical module makers who now compete with a Lumentum business, and that the deal caught investors off guard after the recent analyst day. B. Riley and Stifel cut Lumentum to Neutral and Hold, while Raymond James upgraded it with a USD 1,328 target and Mizuho kept Outperform. The Philadelphia Semiconductor index had fallen 19% over the previous month, according to the BofA note, which compressed sector valuations before the news.

Risks and What to Watch

Lumentum reported fiscal first-quarter Revenue of USD 1.26 billion and EPS of USD 4.57, and guided December-quarter revenue to USD 1.60 billion and EPS to USD 6.05, so the target is expanding quickly. Because the exchange ratio is fixed, the value Lumentum holders receive moves with Marvell's share price, which has already fallen. A review that includes China, integrating two large engineering teams and possible customer conflict are the main risks. Marvell also preliminarily reported fiscal third-quarter revenue and narrowed its guidance range to plus or minus 2%. Marvell Technology (NASDAQ:MRVL) is advised by Qatalyst, J.P. Morgan and Goldman Sachs. Wilson Sonsini is counsel to Marvell and Davis Polk to Lumentum, while Citigroup and Evercore advise Lumentum.

Where Things Stand

Marvell Technology (NASDAQ:MRVL) is paying USD 115 billion to own optical lasers and transceivers as AI networks move toward optical links, and management calls the opportunity once in a generation. For now investors have marked the idea down, with both stocks falling and several analysts downgrading on dilution and regulatory risk. The next milestones are the Form S-4, the shareholder votes, regulatory reviews and Lumentum's December-quarter delivery. The fixed exchange ratio leaves each side exposed to the other's share price until closing.